Infectious Diseases
Latest News
As Omicron surges, hospital beds fill, but ICUs less affected
So far, hospitalizations caused by the Omicron variant appear to be milder than in previous waves.
From the Journals
Freshwater aquarium provides source for melioidosis infection
A careful exposure history is important when there’s an atypical presentation or an infection that is not responding promptly to empiric treatment...
News from the FDA/CDC
Children and COVID: New cases, admissions are higher than ever
There were 2,343 children in U.S. hospitals with confirmed COVID-19 on Jan. 2.
Latest News
COVID-19 outbreak hits research station in Antarctica
Two-thirds of the 25 workers have tested positive at the station, despite all of them being fully vaccinated.
News
FDA backs Pfizer booster for 12- to 15-year-olds
The agency also shortened the recommended time between a second dose and the booster to 5 months or more,
From the Journals
Antiretroviral pill better at suppressing HIV in children
The pill-based regimen reduced the chances of treatment failure among children aged 3-18 by about 40%, compared with other treatments.
Practice Alert
Why mRNA COVID vaccines are preferred (and why patients should be reassured)
On December 16, 2021, the Advisory Committee on Immunization Practices (ACIP) voted to preferentially recommend messenger RNA (mRNA) vaccines over...
News from the FDA/CDC
Children and COVID: Nearly 200,000 new cases reported in 1 week
How many children with COVID-19 are in the hospital on a given day?
From the Journals
Spesolimab speeds lesion clearance in generalized pustular psoriasis
Patients treated with intravenous spesolimab showed significant clearance, but also susceptibility to infections.
News
FDA OKs emergency use of Merck pill for COVID-19
Similar to FDA authorization of another antiviral pill regimen granted to Pfizer, molnupiravir should be taken early in the course of COVID-19...
From the Journals
Bamlanivimab’s effects in COVID-19 depend on antibodies
Bamlanivimab was more effective in hospitalized COVID-19 patients without endogenous neutralizing antibodies.